Wang Qi, Jia Yizhen, Li Jinghua
Department of Materials Science and Engineering, The Ohio State University, Columbus, OH 43210, USA.
Chronic Brain Injury Program, The Ohio State University, Columbus, OH 43210, USA.
Lab Chip. 2025 Aug 5. doi: 10.1039/d5lc00593k.
An essential capability of lab-on-a-chip systems is the precise handling, management, and transport of fluids within microfluidic channels. However, conventional rigid pump-tube-valve systems are often incompatible with emerging wearable and implantable devices, which demand miniaturization, low power consumption, high level of integration, and biocompatibility to ensure reliable and safe operation in biological environments. In recent years, various microscale fluid management and transport strategies have been developed to address these challenges, enabling actively programmable control and significantly advancing the capabilities of bio-integrated electronics. This review summarizes key advances in design architectures, performance control, and integration strategies across four actuation modes: passive, mechanical, pressure-mediated, and electric field-driven mechanisms. Emphasis is placed on their respective advantages and limitations in key application scenarios such as sensing, drug delivery, and biofluid sampling. Finally, we outline potential future directions including device format, comfort level, user safety, and sustained operation, aiming to provide a strategic reference for the development of next-generation fluid management modules in soft bioelectronic systems.
芯片实验室系统的一项基本能力是在微流体通道内精确地处理、管理和传输流体。然而,传统的刚性泵 - 管 - 阀系统通常与新兴的可穿戴和植入式设备不兼容,这些设备需要小型化、低功耗、高度集成以及生物相容性,以确保在生物环境中可靠且安全地运行。近年来,已开发出各种微尺度流体管理和传输策略来应对这些挑战,实现了主动可编程控制,并显著提升了生物集成电子学的能力。本综述总结了四种驱动模式(被动、机械、压力介导和电场驱动机制)在设计架构、性能控制和集成策略方面的关键进展。重点阐述了它们在传感、药物递送和生物流体采样等关键应用场景中的各自优势和局限性。最后,我们概述了潜在的未来发展方向,包括设备形式、舒适度、用户安全性和持续运行,旨在为软生物电子系统中下一代流体管理模块的开发提供战略参考。